Výsledky vyhledávání - "Morenike Fadayomi"

Akademický článek

A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Autor: Veronica Swystun, Francis H. Y. Green, John H. Dennis, Emmanouil Rampakakis, Gurkeet Lalli, Morenike Fadayomi, Andrea Chiu, Grishma Shrestha, Sharif Galal El Shahat, David Evan Nelson, Tamer Y. El Mays, Cora A. Pieron, Richard Leigh

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-8 (2018)

Abstract Background This study evaluates a novel bronchodilator, S1226, for its efficacy in reversing allergen-induced bronchoconstriction in subjects with mild, allergic asthma. S1226 is a new class of bronchodilator that is an aerosol/vapor/gas mix

Externí odkaz: https://doaj.org/article/61a3ccc325354dc2a0cc6f509b77bb8c

Zobrazit plný text záznamu

Plný text ve formátu HTML

Additional file 4: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Autor: Swystun, Veronica, Green, Francis, Dennis, John, Rampakakis, Emmanouil, Gurkeet Lalli, Morenike Fadayomi, Chiu, Andrea, Grishma Shrestha, Shahat, Sharif El, Nelson, David, Mays, Tamer El, Pieron, Cora, Leigh, Richard

Incidence of adverse events (AEs). (DOCX 15 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b3b2f61fc792dfeaf406164c848161

Zobrazit plný text záznamu

Additional file 3: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Adverse events (AEs) by severity, relation to drug, and outcome. (DOCX 14 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b60e3849b4833a90f6bb109aa2008c

Zobrazit plný text záznamu

Additional file 2: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Schedule of assessments during the clinical trial study. (DOCX 102 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c4432ae28e337a955af1721938decf4

Zobrazit plný text záznamu

Additional file 1: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Inclusion and exclusion criteria for participants enrolled in the study (DOCX 18 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012d4f5578a8077f8b6ad01235949f97

Zobrazit plný text záznamu

Additional file 5: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

CONSORT 2010 checklist. (DOC 218 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35da7fd4e7d918c9859a95fba2c00f80

Zobrazit plný text záznamu

A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers

Autor: Gurkeet Lalli, Richard Leigh, David Evan Nelson, Andrea Chiu, John H. Dennis, Morenike Fadayomi, Grishma Shrestha, Francis H. Y. Green, Sharif G. ElShahat, Tamer Y. El Mays, Cora Pieron

Publikováno v: Trials

Background A major challenge in treating acute asthma exacerbations is the need to open constricted airways rapidly enough to reestablish ventilation and allow delivery of conventional medication to diseased airways. The solution requires a new appro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d9d22a3c546ae84bbdd996c2d602f7

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání